USPTO serial 79164728
ORSIRO
Reviewed by CopyMark Law Group
Reg. 4879106Status 739Registered
- Filing date
- Status date
- Registration date
- Jan 5, 2016
- Examiner
- STRUCK, ROBERT J
- Law office
- Historical data usage
What this means
This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.
Need help with ORSIRO?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Jennifer Fraser
Jennifer Fraser Dykema Gossett PLLC1301 K Street, NWSuite 1100 WestWashington, DC 20005Goods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 005 | [ Chemical and pharmaceutical preparations for medical use, namely, medicated polymer-based preparations, including limus preparations of polyester, polylactic limus preparations and inorganic preparations for the treatment of cardiovascular and vascular diseases; chemical and pharmaceutical preparations for medical use for improving the biocompatibility of implants, namely, the coating of stents; chemical and pharmaceutical preparations for medical use for improving the healing of implants, namely, medicated stents; chemical products for pharmaceutical use, namely, medicated polymer-based preparations for the treatment of cardiovascular and vascular diseases; chemical and pharmaceutical preparations for cardiovascular and vascular procedures; drugs for medical use, namely, medicines belonging to the family of limus, namely, derivatives of limus, sirolimus, rapamycin, everolimus, biolimus A9, zotarolimus, tacrolimus and pimecrolimus for the treatment of cardiovascular and vascular diseases; medicines for human use for use in cardiovascular and vascular procedures ] | SECTION 71 - CANCELLED | — |
| 010 | [ Surgical and ] medical apparatus and instruments, namely, [ vascular and ] cardiovascular implants consisting of artificial materials [ and surgical instruments; ] catheters; catheters for percutaneous transluminal coronary angioplasty (PTCA catheters) [ and catheters for percutaneous translumial angioplasty (PTA catheters), ] namely, balloon dilatation catheters; medical apparatus and instruments, namely, balloon catheters and stents; stents which can expand by means of balloons; [ self-expanding stents; ] drug-eluting stents [ ; absorbable stents; absorbable drug-eluting stents ] | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Apr 27, 2026 | NA75 | NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED | — |
| Apr 27, 2026 | C75A | REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK. | — |
| Apr 20, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Dec 23, 2025 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Aug 7, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 5, 2025 | REM4 | COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED | — |
| Nov 28, 2024 | RNWL | INTERNATIONAL REGISTRATION RENEWED | — |
| Mar 28, 2023 | INNP | PARTIAL INVALIDATION PROCESSED BY THE IB | — |
| Feb 24, 2023 | INPS | PARTIAL INVALIDATION OF REG EXT PROTECTION SENT TO IB | — |
| Feb 24, 2023 | INPC | INVALIDATION PROCESSED | — |
| Jan 5, 2023 | INPR | PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED | — |
| May 5, 2022 | NA71 | NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED | — |
| May 5, 2022 | 71.P | REGISTERED - PARTIAL SEC 71 ACCEPTED | — |
| May 5, 2022 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Oct 5, 2021 | ES71 | TEAS SECTION 71 RECEIVED | — |
| Jun 5, 2021 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 5, 2021 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Apr 19, 2018 | CORN | CORRECTION FROM THE IB EXAMINED, NO ACTION IS NEEDED | — |
| Mar 9, 2018 | CRCV | CORRECTION TRANSACTION RECEIVED FROM IB | — |
| May 12, 2017 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 16, 2016 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Apr 6, 2016 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Apr 6, 2016 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Apr 5, 2016 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jan 5, 2016 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Oct 20, 2015 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Oct 20, 2015 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Oct 2, 2015 | TCCA | TEAS CHANGE OF CORRESPONDENCE RECEIVED | — |
| Sep 30, 2015 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Sep 16, 2015 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Sep 11, 2015 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Sep 1, 2015 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Sep 1, 2015 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Aug 24, 2015 | ALIE | ASSIGNED TO LIE | — |
| Aug 5, 2015 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Jul 23, 2015 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jun 7, 2015 | RFNT | REFUSAL PROCESSED BY IB | — |
| May 21, 2015 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| May 21, 2015 | RFRR | REFUSAL PROCESSED BY MPU | — |
| May 21, 2015 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| May 20, 2015 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| May 16, 2015 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| May 12, 2015 | DOCK | ASSIGNED TO EXAMINER | — |
| May 12, 2015 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| May 7, 2015 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |